SPEG Polyclonal Antibody

Rabbit Anti-SPEG Polyclonal Antibody

Product Specifications

Background

SPEG (SPEG Complex Locus) is a Protein Coding gene. Diseases associated with SPEG include Centronuclear Myopathy 5 and Myopathy, Centronuclear, Autosomal Recessive. SPEG encodes a protein with similarity to members of the myosin light chain kinase family. This protein family is required for myocyte cytoskeletal development. Along with the desmin gene, expression of this gene may be controlled by the desmin locus control region. Mutations in SPEG are associated with centronuclear myopathy 5.

CAS Number

9007-83-4

Product Name Alternative

Striated muscle preferentially expressed protein kinase; Aortic preferentially expressed protein 1; APEG-1

Gene ID

10290

Accession Number

Q15772

Reactivity

Human, Rat, Mouse

Immunogen

Synthesized peptide derived from part region of human SPEG protein

Clonality

Polyclonal

Tag

SPEG

Applications

IHC, IF

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

359kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

The antibody detects endogenous levels of SPEG protein

Observed Molecular Weight

359

Formulation

Liquid solution

Buffer pH

PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:50-300; IF 1:50-200